Xenotransplantation Market, Global Outlook and Forecast 2022-2028

June 2022 | 106 pages | ID: XF52EC27C890EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Xenotransplantation in Global, including the following market information:

Global Xenotransplantation Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Xenotransplantation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Organ Preservation Solutions Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Xenotransplantation include Sino-Clone Organ Biotechnology, Qihan Biotech, Grand Life Science & Technology, Geneo, Terumo Medical Corporation, Transonic, Roche, Astellas Pharma and Preservation Solutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Xenotransplantation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Xenotransplantation Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Xenotransplantation Market Segment Percentages, by Type, 2021 (%)

• Organ Preservation Solutions
• Transplant Diagnostics
• Tissue Products

Global Xenotransplantation Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Xenotransplantation Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Transplant Center
• Other

Global Xenotransplantation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Xenotransplantation Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Xenotransplantation revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Xenotransplantation revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sino-Clone Organ Biotechnology
• Qihan Biotech
• Grand Life Science & Technology
• Geneo
• Terumo Medical Corporation
• Transonic
• Roche
• Astellas Pharma
• Preservation Solutions
• OrganOX Limited
• Bio-Med (P) Limited
• TransMedic
• Novartis AG
• Organ Recovery Systems
• Accord Healthcare
• Pfizer
• Veloxis Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Xenotransplantation Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Xenotransplantation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL XENOTRANSPLANTATION OVERALL MARKET SIZE

2.1 Global Xenotransplantation Market Size: 2021 VS 2028
2.2 Global Xenotransplantation Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Xenotransplantation Players in Global Market
3.2 Top Global Xenotransplantation Companies Ranked by Revenue
3.3 Global Xenotransplantation Revenue by Companies
3.4 Top 3 and Top 5 Xenotransplantation Companies in Global Market, by Revenue in 2021
3.5 Global Companies Xenotransplantation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Xenotransplantation Players in Global Market
  3.6.1 List of Global Tier 1 Xenotransplantation Companies
  3.6.2 List of Global Tier 2 and Tier 3 Xenotransplantation Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Xenotransplantation Market Size Markets, 2021 & 2028
  4.1.2 Organ Preservation Solutions
  4.1.3 Transplant Diagnostics
  4.1.4 Tissue Products
4.2 By Type - Global Xenotransplantation Revenue & Forecasts
  4.2.1 By Type - Global Xenotransplantation Revenue, 2017-2022
  4.2.2 By Type - Global Xenotransplantation Revenue, 2023-2028
  4.2.3 By Type - Global Xenotransplantation Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Xenotransplantation Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Transplant Center
  5.1.4 Other
5.2 By Application - Global Xenotransplantation Revenue & Forecasts
  5.2.1 By Application - Global Xenotransplantation Revenue, 2017-2022
  5.2.2 By Application - Global Xenotransplantation Revenue, 2023-2028
  5.2.3 By Application - Global Xenotransplantation Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Xenotransplantation Market Size, 2021 & 2028
6.2 By Region - Global Xenotransplantation Revenue & Forecasts
  6.2.1 By Region - Global Xenotransplantation Revenue, 2017-2022
  6.2.2 By Region - Global Xenotransplantation Revenue, 2023-2028
  6.2.3 By Region - Global Xenotransplantation Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Xenotransplantation Revenue, 2017-2028
  6.3.2 US Xenotransplantation Market Size, 2017-2028
  6.3.3 Canada Xenotransplantation Market Size, 2017-2028
  6.3.4 Mexico Xenotransplantation Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Xenotransplantation Revenue, 2017-2028
  6.4.2 Germany Xenotransplantation Market Size, 2017-2028
  6.4.3 France Xenotransplantation Market Size, 2017-2028
  6.4.4 U.K. Xenotransplantation Market Size, 2017-2028
  6.4.5 Italy Xenotransplantation Market Size, 2017-2028
  6.4.6 Russia Xenotransplantation Market Size, 2017-2028
  6.4.7 Nordic Countries Xenotransplantation Market Size, 2017-2028
  6.4.8 Benelux Xenotransplantation Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Xenotransplantation Revenue, 2017-2028
  6.5.2 China Xenotransplantation Market Size, 2017-2028
  6.5.3 Japan Xenotransplantation Market Size, 2017-2028
  6.5.4 South Korea Xenotransplantation Market Size, 2017-2028
  6.5.5 Southeast Asia Xenotransplantation Market Size, 2017-2028
  6.5.6 India Xenotransplantation Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Xenotransplantation Revenue, 2017-2028
  6.6.2 Brazil Xenotransplantation Market Size, 2017-2028
  6.6.3 Argentina Xenotransplantation Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Xenotransplantation Revenue, 2017-2028
  6.7.2 Turkey Xenotransplantation Market Size, 2017-2028
  6.7.3 Israel Xenotransplantation Market Size, 2017-2028
  6.7.4 Saudi Arabia Xenotransplantation Market Size, 2017-2028
  6.7.5 UAE Xenotransplantation Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sino-Clone Organ Biotechnology
  7.1.1 Sino-Clone Organ Biotechnology Corporate Summary
  7.1.2 Sino-Clone Organ Biotechnology Business Overview
  7.1.3 Sino-Clone Organ Biotechnology Xenotransplantation Major Product Offerings
  7.1.4 Sino-Clone Organ Biotechnology Xenotransplantation Revenue in Global Market (2017-2022)
  7.1.5 Sino-Clone Organ Biotechnology Key News
7.2 Qihan Biotech
  7.2.1 Qihan Biotech Corporate Summary
  7.2.2 Qihan Biotech Business Overview
  7.2.3 Qihan Biotech Xenotransplantation Major Product Offerings
  7.2.4 Qihan Biotech Xenotransplantation Revenue in Global Market (2017-2022)
  7.2.5 Qihan Biotech Key News
7.3 Grand Life Science & Technology
  7.3.1 Grand Life Science & Technology Corporate Summary
  7.3.2 Grand Life Science & Technology Business Overview
  7.3.3 Grand Life Science & Technology Xenotransplantation Major Product Offerings
  7.3.4 Grand Life Science & Technology Xenotransplantation Revenue in Global Market (2017-2022)
  7.3.5 Grand Life Science & Technology Key News
7.4 Geneo
  7.4.1 Geneo Corporate Summary
  7.4.2 Geneo Business Overview
  7.4.3 Geneo Xenotransplantation Major Product Offerings
  7.4.4 Geneo Xenotransplantation Revenue in Global Market (2017-2022)
  7.4.5 Geneo Key News
7.5 Terumo Medical Corporation
  7.5.1 Terumo Medical Corporation Corporate Summary
  7.5.2 Terumo Medical Corporation Business Overview
  7.5.3 Terumo Medical Corporation Xenotransplantation Major Product Offerings
  7.5.4 Terumo Medical Corporation Xenotransplantation Revenue in Global Market (2017-2022)
  7.5.5 Terumo Medical Corporation Key News
7.6 Transonic
  7.6.1 Transonic Corporate Summary
  7.6.2 Transonic Business Overview
  7.6.3 Transonic Xenotransplantation Major Product Offerings
  7.6.4 Transonic Xenotransplantation Revenue in Global Market (2017-2022)
  7.6.5 Transonic Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Xenotransplantation Major Product Offerings
  7.7.4 Roche Xenotransplantation Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Astellas Pharma
  7.8.1 Astellas Pharma Corporate Summary
  7.8.2 Astellas Pharma Business Overview
  7.8.3 Astellas Pharma Xenotransplantation Major Product Offerings
  7.8.4 Astellas Pharma Xenotransplantation Revenue in Global Market (2017-2022)
  7.8.5 Astellas Pharma Key News
7.9 Preservation Solutions
  7.9.1 Preservation Solutions Corporate Summary
  7.9.2 Preservation Solutions Business Overview
  7.9.3 Preservation Solutions Xenotransplantation Major Product Offerings
  7.9.4 Preservation Solutions Xenotransplantation Revenue in Global Market (2017-2022)
  7.9.5 Preservation Solutions Key News
7.10 OrganOX Limited
  7.10.1 OrganOX Limited Corporate Summary
  7.10.2 OrganOX Limited Business Overview
  7.10.3 OrganOX Limited Xenotransplantation Major Product Offerings
  7.10.4 OrganOX Limited Xenotransplantation Revenue in Global Market (2017-2022)
  7.10.5 OrganOX Limited Key News
7.11 Bio-Med (P) Limited
  7.11.1 Bio-Med (P) Limited Corporate Summary
  7.11.2 Bio-Med (P) Limited Business Overview
  7.11.3 Bio-Med (P) Limited Xenotransplantation Major Product Offerings
  7.11.4 Bio-Med (P) Limited Xenotransplantation Revenue in Global Market (2017-2022)
  7.11.5 Bio-Med (P) Limited Key News
7.12 TransMedic
  7.12.1 TransMedic Corporate Summary
  7.12.2 TransMedic Business Overview
  7.12.3 TransMedic Xenotransplantation Major Product Offerings
  7.12.4 TransMedic Xenotransplantation Revenue in Global Market (2017-2022)
  7.12.5 TransMedic Key News
7.13 Novartis AG
  7.13.1 Novartis AG Corporate Summary
  7.13.2 Novartis AG Business Overview
  7.13.3 Novartis AG Xenotransplantation Major Product Offerings
  7.13.4 Novartis AG Xenotransplantation Revenue in Global Market (2017-2022)
  7.13.5 Novartis AG Key News
7.14 Organ Recovery Systems
  7.14.1 Organ Recovery Systems Corporate Summary
  7.14.2 Organ Recovery Systems Business Overview
  7.14.3 Organ Recovery Systems Xenotransplantation Major Product Offerings
  7.14.4 Organ Recovery Systems Xenotransplantation Revenue in Global Market (2017-2022)
  7.14.5 Organ Recovery Systems Key News
7.15 Accord Healthcare
  7.15.1 Accord Healthcare Corporate Summary
  7.15.2 Accord Healthcare Business Overview
  7.15.3 Accord Healthcare Xenotransplantation Major Product Offerings
  7.15.4 Accord Healthcare Xenotransplantation Revenue in Global Market (2017-2022)
  7.15.5 Accord Healthcare Key News
7.16 Pfizer
  7.16.1 Pfizer Corporate Summary
  7.16.2 Pfizer Business Overview
  7.16.3 Pfizer Xenotransplantation Major Product Offerings
  7.16.4 Pfizer Xenotransplantation Revenue in Global Market (2017-2022)
  7.16.5 Pfizer Key News
7.17 Veloxis Pharmaceuticals
  7.17.1 Veloxis Pharmaceuticals Corporate Summary
  7.17.2 Veloxis Pharmaceuticals Business Overview
  7.17.3 Veloxis Pharmaceuticals Xenotransplantation Major Product Offerings
  7.17.4 Veloxis Pharmaceuticals Xenotransplantation Revenue in Global Market (2017-2022)
  7.17.5 Veloxis Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Xenotransplantation Market Opportunities & Trends in Global Market
Table 2. Xenotransplantation Market Drivers in Global Market
Table 3. Xenotransplantation Market Restraints in Global Market
Table 4. Key Players of Xenotransplantation in Global Market
Table 5. Top Xenotransplantation Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Xenotransplantation Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Xenotransplantation Revenue Share by Companies, 2017-2022
Table 8. Global Companies Xenotransplantation Product Type
Table 9. List of Global Tier 1 Xenotransplantation Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Xenotransplantation Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Xenotransplantation Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Xenotransplantation Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Xenotransplantation Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Xenotransplantation Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Xenotransplantation Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Xenotransplantation Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Xenotransplantation Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Xenotransplantation Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Xenotransplantation Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Xenotransplantation Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Xenotransplantation Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Xenotransplantation Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Xenotransplantation Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Xenotransplantation Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Xenotransplantation Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Xenotransplantation Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Xenotransplantation Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Xenotransplantation Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Xenotransplantation Revenue, (US$, Mn), 2023-2028
Table 30. Sino-Clone Organ Biotechnology Corporate Summary
Table 31. Sino-Clone Organ Biotechnology Xenotransplantation Product Offerings
Table 32. Sino-Clone Organ Biotechnology Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 33. Qihan Biotech Corporate Summary
Table 34. Qihan Biotech Xenotransplantation Product Offerings
Table 35. Qihan Biotech Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 36. Grand Life Science & Technology Corporate Summary
Table 37. Grand Life Science & Technology Xenotransplantation Product Offerings
Table 38. Grand Life Science & Technology Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 39. Geneo Corporate Summary
Table 40. Geneo Xenotransplantation Product Offerings
Table 41. Geneo Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 42. Terumo Medical Corporation Corporate Summary
Table 43. Terumo Medical Corporation Xenotransplantation Product Offerings
Table 44. Terumo Medical Corporation Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 45. Transonic Corporate Summary
Table 46. Transonic Xenotransplantation Product Offerings
Table 47. Transonic Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Xenotransplantation Product Offerings
Table 50. Roche Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 51. Astellas Pharma Corporate Summary
Table 52. Astellas Pharma Xenotransplantation Product Offerings
Table 53. Astellas Pharma Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 54. Preservation Solutions Corporate Summary
Table 55. Preservation Solutions Xenotransplantation Product Offerings
Table 56. Preservation Solutions Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 57. OrganOX Limited Corporate Summary
Table 58. OrganOX Limited Xenotransplantation Product Offerings
Table 59. OrganOX Limited Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 60. Bio-Med (P) Limited Corporate Summary
Table 61. Bio-Med (P) Limited Xenotransplantation Product Offerings
Table 62. Bio-Med (P) Limited Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 63. TransMedic Corporate Summary
Table 64. TransMedic Xenotransplantation Product Offerings
Table 65. TransMedic Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 66. Novartis AG Corporate Summary
Table 67. Novartis AG Xenotransplantation Product Offerings
Table 68. Novartis AG Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 69. Organ Recovery Systems Corporate Summary
Table 70. Organ Recovery Systems Xenotransplantation Product Offerings
Table 71. Organ Recovery Systems Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 72. Accord Healthcare Corporate Summary
Table 73. Accord Healthcare Xenotransplantation Product Offerings
Table 74. Accord Healthcare Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 75. Pfizer Corporate Summary
Table 76. Pfizer Xenotransplantation Product Offerings
Table 77. Pfizer Xenotransplantation Revenue (US$, Mn), (2017-2022)
Table 78. Veloxis Pharmaceuticals Corporate Summary
Table 79. Veloxis Pharmaceuticals Xenotransplantation Product Offerings
Table 80. Veloxis Pharmaceuticals Xenotransplantation Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Xenotransplantation Segment by Type in 2021
Figure 2. Xenotransplantation Segment by Application in 2021
Figure 3. Global Xenotransplantation Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Xenotransplantation Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Xenotransplantation Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Xenotransplantation Revenue in 2021
Figure 8. By Type - Global Xenotransplantation Revenue Market Share, 2017-2028
Figure 9. By Application - Global Xenotransplantation Revenue Market Share, 2017-2028
Figure 10. By Region - Global Xenotransplantation Revenue Market Share, 2017-2028
Figure 11. By Country - North America Xenotransplantation Revenue Market Share, 2017-2028
Figure 12. US Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Xenotransplantation Revenue Market Share, 2017-2028
Figure 16. Germany Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 17. France Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Xenotransplantation Revenue Market Share, 2017-2028
Figure 24. China Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 28. India Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Xenotransplantation Revenue Market Share, 2017-2028
Figure 30. Brazil Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Xenotransplantation Revenue Market Share, 2017-2028
Figure 33. Turkey Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Xenotransplantation Revenue, (US$, Mn), 2017-2028
Figure 37. Sino-Clone Organ Biotechnology Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Qihan Biotech Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Grand Life Science & Technology Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Geneo Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Terumo Medical Corporation Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Transonic Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Astellas Pharma Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Preservation Solutions Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. OrganOX Limited Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bio-Med (P) Limited Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. TransMedic Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Novartis AG Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Organ Recovery Systems Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Accord Healthcare Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Pfizer Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Veloxis Pharmaceuticals Xenotransplantation Revenue Year Over Year Growth (US$, Mn) & (2017-2022)